Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04929899 · ClinicalTrials.gov registry record · NA

Bright Ideas - CIN Feasibility Study

A NA study of Acute Lymphoblastic Leukemia (ALL), sponsored by The Hospital for Sick Children.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
4
Study locations

NCT04929899 is a NA study of Acute Lymphoblastic Leukemia (ALL) that is actively recruiting participants, run by The Hospital for Sick Children. The registered enrollment target is 75 participants, below the 6,301-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04929899, a NA study of Acute Lymphoblastic Leukemia (ALL), is actively recruiting participants, sponsored by The Hospital for Sick Children.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
4
Study locations

Study Summary

In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.

Interventions

  • BEHAVIORAL Bright Ideas - CIN Training

Study Locations (4)

California

  • Children's Hospital Los Angeles - Los Angeles

New Jersey

  • Rutgers Cancer Institute - New Brunswick

Virginia

  • Inova Children's Hospital - Falls Church

Ontario

  • Hospital for Sick Children - Toronto

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-03-01
Est. Completion 2025-06
Phase NA

Sponsor

The Hospital for Sick Children

23 total trials

What the Registry Record Tells You About NCT04929899

The ClinicalTrials.gov registry entry for NCT04929899 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,301-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (99% lower). The listed sponsor is The Hospital for Sick Children, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Lymphoblastic Leukemia (ALL) appearing as the primary indexed condition, and to 1 intervention - of which Bright Ideas - CIN Training is the first listed.

NCT04929899 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, New Jersey, Virginia.

Frequently Asked Questions

What is clinical trial NCT04929899 about?

NCT04929899 is a clinical study titled "Bright Ideas - CIN Feasibility Study". In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common tr...

What is the current status of trial NCT04929899?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-03-01. Estimated completion is 2025-06.

What conditions does trial NCT04929899 study?

This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia (ALL).

What interventions are being tested in trial NCT04929899?

The interventions under investigation include: Bright Ideas - CIN Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04929899?

This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04929899 being conducted?

This trial has 4 study locations across California, New Jersey, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Lymphoblastic Leukemia (ALL)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.